Oncolytics Biotech Appoints New CEO to Propel Immunotherapy Advancements Oncolytics Biotech Inc. has appointed Jared Kelly as the new CEO to elevate the company's innovative immunotherapy programs and drive clinical advancements.

Oncolytics Biotech Appoints New CEO to Propel Immunotherapy Advancements #USA #San_Diego #Oncolytics_Biotech #pelareorep #Jared_Kelly